Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
DNAPrint Genomics Inc. (DNAG) had Debt to Equity Ratio of -1.96 for the most recently reported fiscal year, ending 2006-12-31.
| Income Statement Financials | |
$2.43M |
|
$-12.35M |
|
$1.68M |
|
$0.75M |
|
$11.30M |
|
$-8.87M |
|
$-3.48M |
|
$-12.35M |
|
$-14.02M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-14.02M |
|
$-8.87M |
|
$-7.81M |
|
365.24M |
|
365.24M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$8.78M |
|
$1.24M |
|
$1.49M |
|
$10.27M |
|
$13.77M |
|
$0.21M |
|
$0.21M |
|
$13.98M |
|
$-3.71M |
|
$-3.94M |
|
$-3.71M |
|
458.18M |
|
| Cash Flow Statement Financials | |
$-5.78M |
|
$0.16M |
|
$4.41M |
|
$1.81M |
|
$0.59M |
|
$-1.21M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.64 |
|
-- |
|
-- |
|
-0.06 |
|
|
Debt to Equity Ratio |
-1.96 |
30.99% |
|
-364.45% |
|
-364.45% |
|
-321.12% |
|
-507.54% |
|
-507.54% |
|
$-6.17M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
17.41 |
|
32.63 |
|
11.19 |
|
332.78% |
|
313.75% |
|
-120.24% |
|
352.32% |
|
$-0.01 |
|
$-0.02 |
|
$-0.02 |
|